Search research articles
Contact Us
Filters
Showing results (51-60 of 74) with videos related to
Page
of 8
Sort By:
Cancer Letters
|
August 17, 2014
Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFκB-mediated induction of MMP2
Maree Bilandzic, Yao Wang, Nuzhat Ahmed, et al.
The Journal of Endocrinology
|
March 9, 2006
Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins
Paul G Farnworth, Yao Wang, Pauline Leembruggen, et al.
Molecular Endocrinology (Baltimore, Md.)
|
January 17, 2013
Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells
Maree Bilandzic, Simon Chu, Yao Wang, et al.
Molecular Human Reproduction
|
March 26, 2002
Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization
Rebecca L Jones, Lois A Salamonsen, Yi Chen Zhao, et al.
Molecular Human Reproduction
|
May 3, 2003
A novel serine protease of the mammalian HtrA family is up-regulated in mouse uterus coinciding with placentation
Gui-Ying Nie, Ying Li, Hiroyuki Minoura, et al.
Nature Medicine
|
August 8, 2012
Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib
Jeffrey B Kerr, Karla J Hutt, Michele Cook, et al.
Reproduction (Cambridge, England)
|
October 31, 2006
Complex expression patterns support potential roles for maternally derived activins in the establishment of pregnancy in mouse
Rebecca L Jones, Tu'uhevaha J Kaitu'u-Lino, Guiying Nie, et al.
Scientific Reports
|
April 14, 2017
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
Chantel Samardzija, David W Greening, Ruth Escalona, et al.
Frontiers in Oncology
|
May 1, 2014
Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
Khalid Abubaker, Rodney B Luwor, Ruth Escalona, et al.
Molecular Cancer
|
March 30, 2013
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
Khalid Abubaker, Ardian Latifi, Rod Luwor, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 74) with videos related to
Sort By:
Page
of 8
Cancer Letters
|
August 17, 2014
Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFκB-mediated induction of MMP2
Maree Bilandzic, Yao Wang, Nuzhat Ahmed, et al.
The Journal of Endocrinology
|
March 9, 2006
Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins
Paul G Farnworth, Yao Wang, Pauline Leembruggen, et al.
Molecular Endocrinology (Baltimore, Md.)
|
January 17, 2013
Betaglycan alters NFκB-TGFβ2 cross talk to reduce survival of human granulosa tumor cells
Maree Bilandzic, Simon Chu, Yao Wang, et al.
Molecular Human Reproduction
|
March 26, 2002
Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization
Rebecca L Jones, Lois A Salamonsen, Yi Chen Zhao, et al.
Molecular Human Reproduction
|
May 3, 2003
A novel serine protease of the mammalian HtrA family is up-regulated in mouse uterus coinciding with placentation
Gui-Ying Nie, Ying Li, Hiroyuki Minoura, et al.
Nature Medicine
|
August 8, 2012
Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib
Jeffrey B Kerr, Karla J Hutt, Michele Cook, et al.
Reproduction (Cambridge, England)
|
October 31, 2006
Complex expression patterns support potential roles for maternally derived activins in the establishment of pregnancy in mouse
Rebecca L Jones, Tu'uhevaha J Kaitu'u-Lino, Guiying Nie, et al.
Scientific Reports
|
April 14, 2017
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
Chantel Samardzija, David W Greening, Ruth Escalona, et al.
Frontiers in Oncology
|
May 1, 2014
Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
Khalid Abubaker, Rodney B Luwor, Ruth Escalona, et al.
Molecular Cancer
|
March 30, 2013
Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
Khalid Abubaker, Ardian Latifi, Rod Luwor, et al.
Page
of 8